5.14 USD
▲+0.10+1.38%
2026-08-03
市值
$484.44M
市盈率
—
EPS
-0.91
股息率
—
52 周区间
4.75 – 12.25
成交量
6.46K
Beta
1.41
目标价
12.20
52W 低 4.7552W 高 12.25
价格走势
公司简介
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease ca...